4

PRIMARY DOCUMENT

Company: Dianthus Therapeutics, Inc. /DE/
Filed: January 10, 2020
Period of Report: January 10, 2020
Accession Number: 0001562180-20-000327

View Document ↗ View on SEC.gov ↗